Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBunzl Regulatory News (BNZL)

Share Price Information for Bunzl (BNZL)

Share Price is delayed by 15 minutes
Get Live Data
2,420.00    30.00 (1.26%)
Bid:
2,418.00
Ask:
2,422.00
Spread: 4.00 (0.165%)
Market Cap: £7.77b
BNZL Live PriceLast checked at - London Stock Exchange

Intraday Bunzl Share Chart

Trading Statement

22 Apr 2026 07:00

RNS Number : 3653B
Bunzl PLC
22 April 2026
 

22 April 2026

BUNZL Q1 TRADING STATEMENT

TRADING CONSISTENT WITH EXPECTATIONS; 2026 GUIDANCE UNCHANGED

 

Bunzl plc, the specialist international distribution and services Group, today announces its trading statement for the three month period to 31 March 2026.

 

Bunzl has delivered a resilient performance in the first quarter against a backdrop of significant macroeconomic and geopolitical uncertainty. Group revenue in the period grew by 1.5% at constant exchange rates, with underlying revenue1 increasing by 2.0%, supported by both volume growth, in part reflective of easier comparatives, and tariff-related price increases. Acquisitions net of disposals contributed growth of 0.6%, while fewer trading days in the period impacted revenue by 1.1%. At actual exchange rates, Group revenue decreased by 0.4%. Adjusted operating profit over the period was consistent with our expectations for a more stable performance in 2026.

 

North America's underlying revenue growth was slightly ahead of the Group, supported by continued benefit of actions taken to improve performance, including new business won in the second half of 2025. Across the other business areas we saw slight underlying revenue growth in aggregate.

 

While the current geopolitical and macroeconomic environment has become more uncertain, we reiterate our 2026 guidance with performance year-to-date consistent with our expectations. We continue to expect moderate revenue growth at constant exchange rates, driven by some underlying revenue growth and a small benefit from acquisitions, and operating margin to be slightly down year-on-year.

 

Commenting on today's announcement, Frank van Zanten, Chief Executive Officer of Bunzl, said:

 

"The Group continued to deliver underlying revenue growth in the first quarter, supported by actions taken to improve performance and our strengthened focus on organic revenue opportunities. While mindful of the current economic and geopolitical backdrop, the Group reiterates its full year guidance and expects 2026 to be a foundation for future profit growth. Furthermore, there continues to be a significant consolidation opportunity; our pipeline is active and we see an improved outlook for acquisitions in 2026 compared to the prior year. I remain fully confident in our ability to generate long-term compounding growth and value creation for all of our stakeholders."

 

 

 

Enquiries:

Bunzl plc

Frank van Zanten, Chief Executive Officer

Richard Howes, Chief Financial Officer

Sunita Entwisle, Head of Investor Relations and Communications

Tel: +44 (0)20 7725 5000

Teneo

Martin Robinson

Kate Somerville

Tel: +44 (0)20 7353 4200

 

 

1. Underlying revenue is organic revenue adjusted for trading days and net of the benefit of hyperinflationary growth in excess of 26% per annum in Turkey, which had no impact over this period.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTBSGDSGXDDGLB
Date   Source Headline
29th Aug 201712:15 pmRNSDividend Declaration
29th Aug 20177:00 amRNSHalf-year Report
29th Aug 20177:00 amRNSAcquisition
15th Aug 201710:13 amRNSAdditional Listing
9th Aug 20172:56 pmRNSHolding(s) in Company
7th Aug 201712:09 pmRNSHolding(s) in Company
2nd Aug 20172:56 pmRNSHolding(s) in Company
1st Aug 201710:34 amRNSTotal Voting Rights
20th Jul 20177:00 amRNSAcquisition
14th Jul 20171:12 pmRNSDirector/PDMR Shareholding
5th Jul 20173:30 pmRNSDirector/PDMR Shareholding
3rd Jul 20172:01 pmRNSTotal Voting Rights
3rd Jul 20179:50 amRNSHolding(s) in Company
3rd Jul 20179:00 amRNSDirector Declaration
28th Jun 20177:00 amRNSTrading Statement
6th Jun 20171:13 pmRNSDirector/PDMR Shareholding
2nd Jun 20173:51 pmRNSHolding(s) in Company
1st Jun 201710:26 amRNSTotal Voting Rights
24th May 20177:00 amRNSAcquisition
3rd May 20174:47 pmRNSDirector/PDMR Shareholding
3rd May 20174:42 pmRNSBlock listing Interim Review
2nd May 20174:21 pmRNSDirector/PDMR Shareholding
2nd May 20174:19 pmRNSDirector/PDMR Shareholding
2nd May 20173:35 pmRNSTotal Voting Rights
27th Apr 20175:38 pmRNSDirector/PDMR Shareholding
26th Apr 20179:54 amRNSAdditional Listing
19th Apr 20172:20 pmRNSResult of AGM
19th Apr 20177:00 amRNSTrading Statement
13th Apr 20171:56 pmRNSDirector/PDMR Shareholding
13th Apr 201710:21 amRNSAdditional Listing
11th Apr 20175:12 pmRNSDirector/PDMR Shareholding
7th Apr 20175:12 pmRNSDirector/PDMR Shareholding
6th Apr 20174:16 pmRNSDirector/PDMR Shareholding
4th Apr 20174:34 pmRNSDirector/PDMR Shareholding
4th Apr 20177:00 amRNSAcquisition
3rd Apr 20179:43 amRNSTotal Voting Rights
28th Mar 201712:37 pmRNSDirector/PDMR Shareholding
28th Mar 20179:42 amRNSDirectorate Change
16th Mar 20174:28 pmRNSAnnual Financial Report
14th Mar 201711:01 amRNSDirector Declaration
6th Mar 20175:54 pmRNSDirector/PDMR Shareholding
6th Mar 20173:49 pmRNSHolding(s) in Company
3rd Mar 20173:38 pmRNSDirector/PDMR Shareholding
2nd Mar 20174:45 pmRNSDirector/PDMR Shareholding
2nd Mar 20172:10 pmRNSDirector/PDMR Shareholding
1st Mar 20174:27 pmRNSTotal Voting Rights
1st Mar 20177:00 amRNSAcquisition
27th Feb 20171:30 pmRNSDividend Declaration
27th Feb 20177:00 amRNSDirectorate Change
27th Feb 20177:00 amRNSAcquisition

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.